UnitedHealthcare GLP-1 Insurance Coverage

Direct Answer

UnitedHealthcare covers GLP-1 medications through OptumRx, its pharmacy benefit manager, which handles all prior authorization, step therapy, and appeals. Diabetes coverage is consistent: Ozempic and Mounjaro are covered on virtually every UHC commercial plan for type 2 diabetes. Obesity coverage is where real variation exists: Wegovy and Zepbound are covered by roughly 72% of UHC commercial plans, with prior authorization required.

Formulary and Tiers

UHC's 2026 commercial formulary includes six GLP-1 medications: Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, and Rybelsus. Diabetes medications (Ozempic, Mounjaro) are typically Tier 2. Obesity medications (Wegovy, Zepbound) are typically Tier 3.

Prior Authorization Requirements

For diabetes coverage: requires ICD-10 E11 documentation and an HbA1c of 7.0% or higher despite a documented metformin trial (unless contraindicated). For obesity coverage: requires BMI of 30 or higher, or 27 or higher with a qualifying comorbidity. UHC eliminated mandatory step therapy for most obesity-related PAs starting in 2025, a real, meaningful change from prior years.

A Real Distinction Worth Knowing

Wegovy's FDA-approved cardiovascular indication (added March 2024 based on the SELECT trial) opened a separate coverage pathway on most UHC plans, distinct from the general obesity pathway, worth mentioning to your provider if you have documented cardiovascular disease.

Bottom Line

UnitedHealthcare offers genuinely strong diabetes coverage and real, if incomplete, obesity coverage, worth confirming your specific plan's participation directly, since employer group design varies even within UHC's own commercial book.

Coverage policies, prior authorization requirements, and formulary tiers change frequently and vary by specific plan and employer group. This information reflects publicly available data as of August 2026 and should be confirmed directly with your plan.

References

• UnitedHealthcare/OptumRx 2026 Commercial Formulary
• SELECT Trial (Lincoff et al., NEJM 2023)

Browse All Insurance Coverage

See the complete GLP-1 Insurance Coverage hub

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com